Clinical Omics – News and Features
Industry Insight
Bruker Unveils New, Sustainable Manufacturing Facility in Bremen
Bruker Corporation officially opened its new production facility in Bremen – one of Germany’s major science hubs – last week. Technology Networks visited the facility to learn about its low carbon footprint and how it will support Bruker's commitment to innovation and collaboration.
Article
Dissecting the Proteome To Understand Disease
Proteomics provides insights into the regulation of biological processes and mechanisms of disease. In this article, we explore approaches scientists are using to find early markers of disease, new drug targets and strategies to overcome resistance to treatments.
News
Diagnostic Test Detects Ovarian Cancer With 93% Accuracy
Researchers have developed a machine learning-based classifier, which utilizes metabolic profiles of serum samples, to accurately identify people with ovarian cancer.
News
Scientists Find a Method To Predict Which of Our Organs Will Fail First
A new study led by Stanford Medicine scientists demonstrates a simple way of studying organ aging by analyzing distinct proteins, or sets of them, in blood, enabling the prediction of individuals’ risk for diseases.
News
Simple Way To Measure Organ Aging Developed
A test that analyzes specific sets of proteins in the blood can tell us how fast each of our organs is aging, enabling the prediction of disease risk and earlier intervention.
Article
Trends and Advancements in Proteomics
Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.
Industry Insight
Failing Faster To Succeed Sooner in Drug Discovery
Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
News
Liquid Biopsy Predicts Early Disease Progression in Breast Cancer Patients
A liquid biopsy that measures DNA methylation has predicted early disease progression and potential survival in breast cancer patients.
Article
The Power and Potential of Epigenetic Aging Clocks
In this article, we take a deep dive into the world of epigenetic aging clocks, finding out what they are, what they can tell us and how they might be applied in future.
Industry Insight
A Decade of DIA and Key Milestones: The 10-Year Anniversary of SWATH DIA
The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.
Advertisement